Australian medical device company ITL BioMedical, a division of ITL, has globally launched its patented DonorCare Needle Guard 2 at the American Association of Blood Banks (AABB) Annual Meeting in Florida.
The DonorCare Needle Guard 2 is designed for safe and fast needle withdrawal, immediately shielding the whole blood collection needle in a secure, one-piece housing, which in turn reduces potential exposure to needle stick injury.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
With a simple and user-friendly design, the product requires minimal training and can be easily incorporated into existing processes.
It is incorporated with features allowing a visual confirmation of the needle being safely locked which is ensured with an audible click sound.
It comes with enhanced features including visual confirmation that the needle is safely locked in place, along with an audible click.
Its low-profile design also eliminates risks of accidental needle movement and withdrawal.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataITL BioMedical executive chairman Bill Mobbs said: "It is very rewarding to take a global industry standard product up to the next level.
"As with all of our innovative products, DonorCare Needle Guard 2 was designed with end user input from the beginning, and we feel confident this product will be as successful as its predecessor."
Image: DonorCare Needle Guard 2. Photo: courtesy of ITL BioMedical.
